Journal of Clinical Oncology· 2012Q1

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn, Johan M. Kros et al.

1,227citations
Q1SCImago
2012year

Short summary

Adding six cycles of procarbazine, lomustine, and vincristine (PCV) chemotherapy to radiotherapy (RT) significantly increased overall survival (OS) and progression-free survival (PFS) in patients with newly diagnosed anaplastic oligodendroglioma.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Genetics

GeneticsMedicine